FdaApplication
ANDA 206387
Identifiers
- fda_app_no: ANDA206387
Properties
| Property | Value |
|---|---|
| applicant_name | IPCA LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2024-06-04 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 35MG BASE | TABLET;ORAL |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 40MG BASE | TABLET;ORAL |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 70MG BASE | TABLET;ORAL |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 10MG BASE | TABLET;ORAL |
4 products